10-Q Filing

BNB PLUS CORP. CIK: 744452 Q2 2023

Filing Information

Form Type	10-Q
Accession Number	`0001410578-23-001014`
Period End Date	20230331
Filing Date	20230511
Fiscal Year	2023
Fiscal Period	Q2
XBRL Instance	apdn-20230331x10q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 71 Income Statement 88 Cash Flow Statement 64 Stockholders Equity 29

Balance Sheet 71 line items

Line Item	Tag	Value	Unit	Period
Allowance on accounts receivable (in dollars)	`AllowanceForDoubtfulAccountsReceivableCurrent`	$40.83K	USD	Point-in-time
Allowance on accounts receivable (in dollars)	`AllowanceForDoubtfulAccountsReceivableCurrent`	$330.85K	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$12.29M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$15.22M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Accounts receivable, net of allowance of $40,831 and $330,853 at March 31, 2023 and September 30, 2022, respectively	`AccountsReceivableNetCurrent`	$1.97M	USD	Point-in-time
Accounts receivable, net of allowance of $40,831 and $330,853 at March 31, 2023 and September 30, 2022, respectively	`AccountsReceivableNetCurrent`	$3.07M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Inventories	`InventoryNet`	$602.24K	USD	Point-in-time
Inventories	`InventoryNet`	$366.08K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$758.53K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.06M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$15.38M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$19.94M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.22M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	12.91M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$1.58M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	12.91M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	12.91M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	12.91M	shares	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$750.00K	USD	Point-in-time
Right of use asset	`OperatingLeaseRightOfUseAsset`	$1.47M	USD	Point-in-time
Deposits	`DepositsAssetsNoncurrent`	$99.00K	USD	Point-in-time
Total assets	`Assets`	$22.27M	USD	Point-in-time
Total assets	`Assets`	$19.18M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$2.90M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$3.62M	USD	Point-in-time
Lease liability, current	`OperatingLeaseLiabilityCurrent`	$476.50K	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$283.30K	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$563.56K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$4.19M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$3.66M	USD	Point-in-time
Long term accrued liabilities	`AccountsPayableAndAccruedLiabilitiesNoncurrent`	$31.47K	USD	Point-in-time
Long term accrued liabilities	`AccountsPayableAndAccruedLiabilitiesNoncurrent`	$31.47K	USD	Point-in-time
Lease liability, long term	`OperatingLeaseLiabilityNoncurrent`	$994.11K	USD	Point-in-time
Warrants classified as a liability	`CommonWarrantLiabilityNoncurrent`	$4.53M	USD	Point-in-time
Warrants classified as a liability	`CommonWarrantLiabilityNoncurrent`	$5.14M	USD	Point-in-time
Total liabilities	`Liabilities`	$9.21M	USD	Point-in-time
Total liabilities	`Liabilities`	$9.36M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- shares issued and outstanding as of March 31, 2023 and September 30, 2022, respectively	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- shares issued and outstanding as of March 31, 2023 and September 30, 2022, respectively	`PreferredStockValue`	-	USD	Point-in-time
Common stock, par value $0.001 per share; 200,000,000 shares authorized as of March 31, 2023 and September 30, 2022, 12,908,520 shares issued and outstanding as of March 31, 2023 and September 30, 2022	`CommonStockValue`	$12.91K	USD	Point-in-time
Common stock, par value $0.001 per share; 200,000,000 shares authorized as of March 31, 2023 and September 30, 2022, 12,908,520 shares issued and outstanding as of March 31, 2023 and September 30, 2022	`CommonStockValue`	$12.91K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$305.75M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$305.40M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-292.50M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-295.76M	USD	Point-in-time
Applied DNA Sciences, Inc. stockholders' equity	`StockholdersEquity`	$10.01M	USD	Point-in-time
Applied DNA Sciences, Inc. stockholders' equity	`StockholdersEquity`	$12.91M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$-2.89K	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$-40.93K	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$7.65M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$9.16M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$8.39M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$12.91M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$11.11M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$9.97M	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$22.27M	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$19.18M	USD	Point-in-time

Income Statement 88 line items

Line Item	Tag	Value	Unit	Period
Total revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$4.41M	USD	1 Quarter
Total revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$9.67M	USD	2 Qtrs
Total revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$6.15M	USD	1 Quarter
Total revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$10.31M	USD	2 Qtrs
Total cost of revenues	`CostOfRevenue`	$3.66M	USD	1 Quarter
Total cost of revenues	`CostOfRevenue`	$5.49M	USD	2 Qtrs
Total cost of revenues	`CostOfRevenue`	$6.72M	USD	2 Qtrs
Total cost of revenues	`CostOfRevenue`	$2.60M	USD	1 Quarter
Gross profit	`GrossProfit`	$1.81M	USD	1 Quarter
Gross profit	`GrossProfit`	$4.19M	USD	2 Qtrs
Gross profit	`GrossProfit`	$3.60M	USD	2 Qtrs
Gross profit	`GrossProfit`	$2.49M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$8.31M	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$3.52M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$6.15M	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$3.57M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.96M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.07M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$2.15M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$988.74K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$4.64M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$10.46M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$8.11M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$4.51M	USD	1 Quarter
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-2.15M	USD	1 Quarter
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-3.92M	USD	2 Qtrs
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-2.70M	USD	1 Quarter
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-6.86M	USD	2 Qtrs
Interest income	`InterestIncomeExpenseNet`	$7.33K	USD	2 Qtrs
Interest income	`InterestIncomeExpenseNet`	$5.54K	USD	1 Quarter
Interest income	`InterestIncomeExpenseNet`	$5.81K	USD	2 Qtrs
Interest income	`InterestIncomeExpenseNet`	$3.64K	USD	1 Quarter
Transaction cost allocated to warrant liabilities	`TransactionCostAllocatedToWarrantLiabilities`	$-391.33K	USD	1 Quarter
Transaction cost allocated to warrant liabilities	`TransactionCostAllocatedToWarrantLiabilities`	-	USD	1 Quarter
Transaction cost allocated to warrant liabilities	`TransactionCostAllocatedToWarrantLiabilities`	$-391.33K	USD	2 Qtrs
Unrealized gain on change in fair value of warrants classified as a liability	`FairValueAdjustmentOfWarrants`	$-3.25M	USD	1 Quarter
Unrealized gain on change in fair value of warrants classified as a liability	`FairValueAdjustmentOfWarrants`	$-782.50K	USD	1 Quarter
Unrealized gain on change in fair value of warrants classified as a liability	`FairValueAdjustmentOfWarrants`	$-613.10K	USD	2 Qtrs
Unrealized gain on change in fair value of warrants classified as a liability	`FairValueAdjustmentOfWarrants`	$-782.50K	USD	2 Qtrs
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$661.00	USD	1 Quarter
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$-16.87K	USD	2 Qtrs
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$9.51K	USD	2 Qtrs
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$-2.27K	USD	1 Quarter
Income (loss) before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-3.29M	USD	2 Qtrs
Income (loss) before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-6.48M	USD	2 Qtrs
Income (loss) before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-1.76M	USD	1 Quarter
Income (loss) before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$551.18K	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	2 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	2 Qtrs
NET INCOME (LOSS)	`ProfitLoss`	$-3.84M	USD	1 Quarter
NET INCOME (LOSS)	`ProfitLoss`	$551.18K	USD	1 Quarter
NET INCOME (LOSS)	`ProfitLoss`	$-6.48M	USD	2 Qtrs
NET INCOME (LOSS)	`ProfitLoss`	$-4.72M	USD	1 Quarter
NET INCOME (LOSS)	`ProfitLoss`	$-3.29M	USD	2 Qtrs
NET INCOME (LOSS)	`ProfitLoss`	$-1.76M	USD	1 Quarter
Less: Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-1.11K	USD	1 Quarter
Less: Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-37.17K	USD	1 Quarter
Less: Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-38.04K	USD	2 Qtrs
Less: Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-257.00	USD	2 Qtrs
NET INCOME (LOSS) attributable to Applied DNA Sciences, Inc.	`NetIncomeLoss`	$-3.26M	USD	2 Qtrs
NET INCOME (LOSS) attributable to Applied DNA Sciences, Inc.	`NetIncomeLoss`	$588.34K	USD	1 Quarter
NET INCOME (LOSS) attributable to Applied DNA Sciences, Inc.	`NetIncomeLoss`	$-1.76M	USD	1 Quarter
NET INCOME (LOSS) attributable to Applied DNA Sciences, Inc.	`NetIncomeLoss`	$-6.48M	USD	2 Qtrs
Deemed dividend related to warrant modification	`DeemedDividendRelatedToWarrantModifications`	$110.11K	USD	2 Qtrs
Deemed dividend related to warrant modification	`DeemedDividendRelatedToWarrantModifications`	$110.11K	USD	1 Quarter
Deemed dividend related to warrant modification	`DeemedDividendRelatedToWarrantModifications`	-	USD	1 Quarter
NET INCOME (LOSS) attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$588.34K	USD	1 Quarter
NET INCOME (LOSS) attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-3.26M	USD	2 Qtrs
NET INCOME (LOSS) attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-6.59M	USD	2 Qtrs
NET INCOME (LOSS) attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-1.87M	USD	1 Quarter
Net income (loss) per share attributable to common stockholders-basic	`EarningsPerShareBasic`	$-0.23	USD	1 Quarter
Net income (loss) per share attributable to common stockholders-basic	`EarningsPerShareBasic`	$0.05	USD	1 Quarter
Net income (loss) per share attributable to common stockholders-basic	`EarningsPerShareBasic`	$-0.25	USD	2 Qtrs
Net income (loss) per share attributable to common stockholders-basic	`EarningsPerShareBasic`	$-0.85	USD	2 Qtrs
Net income (loss) per share attributable to common stockholders- diluted	`EarningsPerShareDiluted`	$0.05	USD	1 Quarter
Net income (loss) per share attributable to common stockholders- diluted	`EarningsPerShareDiluted`	$-0.25	USD	2 Qtrs
Net income (loss) per share attributable to common stockholders- diluted	`EarningsPerShareDiluted`	$-0.85	USD	2 Qtrs
Net income (loss) per share attributable to common stockholders- diluted	`EarningsPerShareDiluted`	$-0.23	USD	1 Quarter
Weighted average shares outstanding - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	12.91M	shares	1 Quarter
Weighted average shares outstanding - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	8.08M	shares	1 Quarter
Weighted average shares outstanding - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	7.78M	shares	2 Qtrs
Weighted average shares outstanding - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	12.91M	shares	2 Qtrs
Weighted average shares outstanding - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	12.91M	shares	1 Quarter
Weighted average shares outstanding - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	8.08M	shares	1 Quarter
Weighted average shares outstanding - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	12.91M	shares	2 Qtrs
Weighted average shares outstanding - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	7.78M	shares	2 Qtrs

Cash Flow Statement 64 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-3.84M	USD	1 Quarter
Net loss	`ProfitLoss`	$551.18K	USD	1 Quarter
Net loss	`ProfitLoss`	$-6.48M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-4.72M	USD	1 Quarter
Net loss	`ProfitLoss`	$-3.29M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-1.76M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$683.42K	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$641.62K	USD	2 Qtrs
Gain on sale of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	-	USD	2 Qtrs
Gain on sale of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$6.08K	USD	2 Qtrs
Unrealized gain on change in fair value of warrants classified as a liability	`FairValueAdjustmentOfWarrants`	$-3.25M	USD	1 Quarter
Unrealized gain on change in fair value of warrants classified as a liability	`FairValueAdjustmentOfWarrants`	$-782.50K	USD	1 Quarter
Unrealized gain on change in fair value of warrants classified as a liability	`FairValueAdjustmentOfWarrants`	$-613.10K	USD	2 Qtrs
Unrealized gain on change in fair value of warrants classified as a liability	`FairValueAdjustmentOfWarrants`	$-782.50K	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$352.35K	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$1.97M	USD	2 Qtrs
Change in provision for bad debts	`ProvisionForDoubtfulAccounts`	$10.00K	USD	2 Qtrs
Change in provision for bad debts	`ProvisionForDoubtfulAccounts`	$-290.02K	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-1.39M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-206.23K	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$-236.16K	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$-725.97K	USD	2 Qtrs
Prepaid expenses and other current assets and deposits	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$842.07K	USD	2 Qtrs
Prepaid expenses and other current assets and deposits	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-398.52K	USD	2 Qtrs
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$472.20K	USD	2 Qtrs
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-746.50K	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenues`	$112.66K	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenues`	$-280.26K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-2.17M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-3.96M	USD	2 Qtrs
Proceeds from sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	-	USD	2 Qtrs
Proceeds from sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$45.00K	USD	2 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$170.22K	USD	2 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$54.34K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-170.22K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-9.34K	USD	2 Qtrs
Net proceeds from issuance of common stock and warrants	`NetProceedsFromSaleOfCommonStockAndWarrants`	-	USD	2 Qtrs
Net proceeds from issuance of common stock and warrants	`NetProceedsFromSaleOfCommonStockAndWarrants`	$4.09M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	-	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$4.09M	USD	2 Qtrs
Net decrease in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-42.16K	USD	2 Qtrs
Net decrease in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-2.18M	USD	2 Qtrs
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$15.22M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.51M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$13.04M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.55M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$15.22M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.51M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$13.04M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.55M	USD	Point-in-time
Cash paid during period for interest	`InterestPaidNet`	-	USD	2 Qtrs
Cash paid during period for interest	`InterestPaidNet`	-	USD	2 Qtrs
Cash paid during period for income taxes	`IncomeTaxesPaid`	-	USD	2 Qtrs
Cash paid during period for income taxes	`IncomeTaxesPaid`	-	USD	2 Qtrs
Property and equipment acquired, and included in accounts payable	`PropertyPlantAndEquipmentAcquiredAndIncludedInAccountsPayable`	$76.18K	USD	2 Qtrs
Property and equipment acquired, and included in accounts payable	`PropertyPlantAndEquipmentAcquiredAndIncludedInAccountsPayable`	$20.32K	USD	2 Qtrs
Deemed dividend warrant modifications	`DeemedDividendWarrantModifications`	$110.11K	USD	2 Qtrs
Deemed dividend warrant modifications	`DeemedDividendWarrantModifications`	-	USD	2 Qtrs
Leased assets obtained in exchange for new operating lease liabilities	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$1.55M	USD	2 Qtrs
Leased assets obtained in exchange for new operating lease liabilities	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	-	USD	2 Qtrs
Fair value of warrants issued	`FairValueOfWarrantsIssued`	-	USD	2 Qtrs
Fair value of warrants issued	`FairValueOfWarrantsIssued`	$3.35M	USD	2 Qtrs
Issuance of stock options for payment of accrued bonus	`IssuanceOfStockOptionsIssuedForPaymentOfAccruedBonus`	-	USD	2 Qtrs
Issuance of stock options for payment of accrued bonus	`IssuanceOfStockOptionsIssuedForPaymentOfAccruedBonus`	$300.00K	USD	2 Qtrs

Stockholders Equity 29 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$7.65M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$9.16M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$8.39M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$12.91M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$11.11M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$9.97M	USD	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	12.91M	shares	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	12.91M	shares	Point-in-time
Stock based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$93.75K	USD	1 Quarter
Stock based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.70M	USD	1 Quarter
Stock based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$272.92K	USD	1 Quarter
Stock based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$258.60K	USD	1 Quarter
Common stock issued in public offering, net of offering costs	`SharesIssuedInPublicOffering`	$-4.09M	USD	1 Quarter
Fair value of warrants issued in connection with public offering	`WarrantsIssuedDuringPeriodValueWarrants`	$-3.35M	USD	1 Quarter
Options issued in settlement of accrued bonus	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$300.00K	USD	1 Quarter
Net loss	`ProfitLoss`	$-3.84M	USD	1 Quarter
Net loss	`ProfitLoss`	$551.18K	USD	1 Quarter
Net loss	`ProfitLoss`	$-6.48M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-4.72M	USD	1 Quarter
Net loss	`ProfitLoss`	$-3.29M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-1.76M	USD	1 Quarter
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$7.65M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$9.16M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$8.39M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$12.91M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$11.11M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$9.97M	USD	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	12.91M	shares	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	12.91M	shares	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.